Form 4 for TLSI TriSalus Life Sciences, Inc.
Accepted 2025-05-21 00:00:00 ET · period of report 2025-05-19 · accession 0001826667-25-000063 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-21 | 2025-05-19 | TLSI | Young James Emmett | CFO | A - Grant | $5.18 | +13.2K | 49.7K | +36% | +$68.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-19 | A | A | 13,175 | $5.18 | 49,663 | D | — | — | (F1) The granted RSUs vest immediately. |